Alzheimer's drug adoption in U.S. slowed by doctors' skepticism

By CTV News
| April 24, 2024

Fewer than half of U.S. neurologists recommend Leqembi to patients, according to a January survey.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...